Topotecan Hospira 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification
Decision 
Information 
1 issued on 
Issued2 / 
affected3  
amended 
on 
IB/0048/G 
This was an application for a group of variations. 
01/08/2022 
SmPC, Annex 
C.I.2.a: to update section 4.4 and 5.1 of the SmPC to be in 
C.I.2.a - Change in the SPC, Labelling or PL of a 
generic/hybrid/biosimilar products following 
assessment of the same change for the reference 
product - Implementation of change(s) for which NO 
II, Labelling 
line with the reference product, following assessment of the 
and PL 
same changes for reference product. Package Leaflet has 
been updated accordingly. 
In addition, the MAH took the opportunity to implement 
minor changes in the PI: update to current QRD template 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
new additional data is required to be submitted by 
and update of local representative for NL.  
the MAH 
A.6 - Administrative change - Change in ATC 
Code/ATC Vet Code 
A.5.a - Administrative change - Change in the name 
and/or address of a manufacturer/importer 
responsible for batch release 
A.5.a: change in company name of a registered batch 
release site; update to the to Annex II and the package 
leaflet. 
A.6: to update the ATC code in section 5.1 of the SmPC. 
IB/0045 
B.II.f.1.e - Stability of FP - Change to an approved 
07/03/2022 
n/a 
stability protocol 
N/0047 
Minor change in labelling or package leaflet not 
01/03/2022 
PL 
connected with the SPC (Art. 61.3 Notification) 
IA/0046 
B.I.b.1.d - Change in the specification parameters 
14/02/2022 
n/a 
and/or limits of an AS, starting 
material/intermediate/reagent - Deletion of a non-
significant specification parameter (e.g. deletion of 
an obsolete parameter) 
IB/0044/G 
This was an application for a group of variations. 
12/11/2021 
n/a 
B.II.z - Quality change - Finished product - Other 
variation 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.II.d.2.a - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
B.II.d.2.a - Change in test procedure for the finished 
Page 2/11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
product - Minor changes to an approved test 
procedure 
B.II.b.3.a - Change in the manufacturing process of 
the finished or intermediate product - Minor change 
in the manufacturing process 
N/0043 
Minor change in labelling or package leaflet not 
01/10/2021 
PL 
connected with the SPC (Art. 61.3 Notification) 
IA/0042 
A.7 - Administrative change - Deletion of 
09/02/2021 
22/10/2021 
Annex II and 
manufacturing sites 
PL 
PSUSA/2997/
Periodic Safety Update EU Single assessment - 
14/01/2021 
n/a 
PRAC Recommendation - maintenance 
202005 
topotecan 
IB/0040 
C.I.z - Changes (Safety/Efficacy) of Human and 
04/01/2021 
22/10/2021 
SmPC, Annex 
Veterinary Medicinal Products - Other variation 
II, Labelling 
and PL 
IA/0041 
A.7 - Administrative change - Deletion of 
22/10/2020 
22/10/2021 
Annex II and 
manufacturing sites 
N/0038 
Minor change in labelling or package leaflet not 
07/10/2020 
22/10/2021 
connected with the SPC (Art. 61.3 Notification) 
PL 
PL 
N/0037 
Minor change in labelling or package leaflet not 
02/12/2019 
22/10/2021 
PL 
connected with the SPC (Art. 61.3 Notification) 
N/0036 
Minor change in labelling or package leaflet not 
09/04/2019 
05/12/2019 
PL 
connected with the SPC (Art. 61.3 Notification) 
Page 3/11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IAIN/0035/G 
This was an application for a group of variations. 
12/12/2018 
05/12/2019 
Annex II and 
PL 
A.7 - Administrative change - Deletion of 
manufacturing sites 
B.II.b.2.c.1 - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
N/0034 
Minor change in labelling or package leaflet not 
24/10/2018 
05/12/2019 
PL 
connected with the SPC (Art. 61.3 Notification) 
T/0033 
Transfer of Marketing Authorisation 
06/08/2018 
20/09/2018 
SmPC, 
Labelling and 
PL 
IB/0032 
C.I.2.a - Change in the SPC, Labelling or PL of a 
13/04/2018 
20/09/2018 
SmPC, Annex 
generic/hybrid/biosimilar products following 
assessment of the same change for the reference 
product - Implementation of change(s) for which NO 
new additional data is required to be submitted by 
the MAH 
II and PL 
N/0031 
Minor change in labelling or package leaflet not 
16/11/2017 
20/09/2018 
PL 
connected with the SPC (Art. 61.3 Notification) 
N/0030 
Minor change in labelling or package leaflet not 
16/02/2017 
20/09/2018 
Labelling and 
connected with the SPC (Art. 61.3 Notification) 
PL 
IB/0029/G 
This was an application for a group of variations. 
09/01/2017 
n/a 
Page 4/11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.I.d.1.a.4 - Stability of AS - Change in the re-test 
period/storage period - Extension or introduction of a 
re-test period/storage period supported by real time 
data 
B.I.d.1.b.3 - Stability of AS - Change in the storage 
conditions - Change in storage conditions of the AS 
N/0028 
Update of the package leaflet with revised contact 
17/06/2016 
14/11/2016 
PL 
details of the local representatives for Belgium, 
Germany, Spain, Ireland, Luxembourg, the 
Netherlands, Austria and Portugal. 
Minor change in labelling or package leaflet not 
connected with the SPC (Art. 61.3 Notification) 
IG/0693 
B.II.b.1.a - Replacement or addition of a 
02/06/2016 
n/a 
manufacturing site for the FP - Secondary packaging 
site 
PSUSA/2997/
Periodic Safety Update EU Single assessment - 
14/01/2016 
n/a 
PRAC Recommendation - maintenance 
201505 
topotecan 
IG/0645 
C.I.8.a - Introduction of or changes to a summary of 
17/12/2015 
n/a 
Pharmacovigilance system - Changes in QPPV 
(including contact details) and/or changes in the 
PSMF location 
IAIN/0024/G 
This was an application for a group of variations. 
24/11/2015 
14/11/2016 
SmPC, Annex 
A.1 - Administrative change - Change in the name 
and/or address of the MAH 
II, Labelling 
and PL 
Page 5/11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.II.b.2.c.1 - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
IB/0022/G 
This was an application for a group of variations. 
13/08/2015 
n/a 
B.II.e.2.a - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Tightening of specification limits 
B.II.e.2.a - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Tightening of specification limits 
B.II.e.2.b - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Addition of a new specification 
parameter to the specification with its corresponding 
test method 
B.II.e.2.b - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Addition of a new specification 
parameter to the specification with its corresponding 
test method 
B.II.e.2.c - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Deletion of a non-significant 
specification parameter (e.g. deletion of an obsolete 
parameter) 
B.II.e.2.c - Change in the specification parameters 
and/or limits of the immediate packaging of the 
Page 6/11 
 
 
 
 
 
 
 
 
 
finished product - Deletion of a non-significant 
specification parameter (e.g. deletion of an obsolete 
parameter) 
B.II.e.2.z - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Other variation 
B.II.e.6.b - Change in any part of the (primary) 
packaging material not in contact with the finished 
product formulation - Change that does not affect 
the product information 
R/0019 
Renewal of the marketing authorisation. 
26/03/2015 
28/05/2015 
IG/0555 
C.I.8.a - Introduction of or changes to a summary of 
22/05/2015 
n/a 
Pharmacovigilance system - Changes in QPPV 
(including contact details) and/or changes in the 
PSMF location 
IB/0020 
C.I.2.a - Change in the SPC, Labelling or PL of a 
19/12/2014 
28/05/2015 
SmPC, 
generic/hybrid/biosimilar products following 
assessment of the same change for the reference 
product - Implementation of change(s) for which NO 
new additional data is required to be submitted by 
the MAH 
Labelling and 
PL 
IAIN/0018 
B.II.b.1.a - Replacement or addition of a 
03/10/2014 
n/a 
manufacturing site for the FP - Secondary packaging 
site 
IAIN/0017/G 
This was an application for a group of variations. 
04/09/2014 
n/a 
Page 7/11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A.5.b - Administrative change - Change in the name 
and/or address of a manufacturer/importer of the 
finished product, including quality control sites 
(excluding manufacturer for batch release) 
A.7 - Administrative change - Deletion of 
manufacturing sites 
B.II.b.1.a - Replacement or addition of a 
manufacturing site for the FP - Secondary packaging 
site 
A.7 - Administrative change - Deletion of 
manufacturing sites 
IG/0477 
C.I.8.a - Introduction of or changes to a summary of 
03/09/2014 
n/a 
Pharmacovigilance system - Changes in QPPV 
(including contact details) and/or changes in the 
PSMF location 
IG/0382 
C.I.8.a - Introduction of or changes to a summary of 
02/12/2013 
n/a 
Pharmacovigilance system - Changes in QPPV 
(including contact details) and/or changes in the 
PSMF location 
IAIN/0013 
B.II.b.2.b.1 - Change to batch release arrangements 
23/07/2013 
27/06/2014 
Annex II and 
and quality control testing of the FP - Not including 
PL 
batch control/testing 
IG/0317 
C.I.z - Changes (Safety/Efficacy) of Human and 
23/07/2013 
n/a 
Veterinary Medicinal Products - Other variation 
IAIN/0011 
B.II.b.1.a - Replacement or addition of a 
23/04/2013 
n/a 
manufacturing site for the FP - Secondary packaging 
Page 8/11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
site 
IG/0286 
C.I.z - Changes (Safety/Efficacy) of Human and 
12/04/2013 
n/a 
Veterinary Medicinal Products - Other variation 
N/0009 
Update of contact details of the local representatives 
11/10/2012 
29/10/2012 
PL 
in the package leaflet. 
Minor change in labelling or package leaflet not 
connected with the SPC (Art. 61.3 Notification) 
IAIN/0008/G 
This was an application for a group of variations. 
25/06/2012 
n/a 
B.II.b.2.a - Change to batch release arrangements 
and quality control testing of the FP - Replacement 
or addition of a site where batch control/testing 
takes place 
B.II.b.1.a - Replacement or addition of a 
manufacturing site for the FP - Secondary packaging 
site 
IB/0007 
B.II.f.1.b.1 - Stability of FP - Extension of the shelf 
07/06/2012 
29/10/2012 
SmPC 
life of the finished product - As packaged for sale 
(supported by real time data) 
IAIN/0006/G 
This was an application for a group of variations. 
18/04/2012 
n/a 
C.I.9.a - Changes to an existing pharmacovigilance 
system as described in the DDPS - Change in the 
QPPV 
C.I.9.c - Changes to an existing pharmacovigilance 
Page 9/11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
system as described in the DDPS - Change of the 
back-up procedure of the QPPV 
C.I.9.e - Changes to an existing pharmacovigilance 
system as described in the DDPS - Changes in the 
major contractual arrangements with other persons 
or organisations involved in the fulfilment of 
pharmacovigilance obligations and described in the 
DD 
C.I.9.g - Changes to an existing pharmacovigilance 
system as described in the DDPS - Change of the site 
undertaking pharmacovigilance activities 
C.I.9.h - Changes to an existing pharmacovigilance 
system as described in the DDPS - Other change(s) 
to the DDPS that does not impact on the operation of 
the pharmacovigilance system 
IB/0004 
C.I.2.a - Change in the SPC, Labelling or PL of a 
11/11/2011 
15/05/2012 
SmPC and PL 
To align the Topotecan Hospira PI with that of the Hycamtin 
generic/hybrid/biosimilar products following 
assessment of the same change for the reference 
product - Implementation of change(s) for which NO 
new additional data are submitted by the MAH 
reference product, by inserting details of the ovarian cancer 
indication currently approved in the innovator text. Minor 
typographical/administrative changes have also  been 
made to some texts to align with that of the innovator. 
IB/0005 
B.II.f.1.b.1 - Stability of FP - Extension of the shelf 
25/10/2011 
n/a 
SmPC 
life of the finished product - As packaged for sale 
(supported by real time data) 
IB/0003 
C.I.2.a - Change in the SPC, Labelling or PL of a 
25/02/2011 
n/a 
SmPC and PL 
The MAH applied to bring the SmPC in line to reflect the 
generic/hybrid/biosimilar products following 
assessment of the same change for the reference 
product - Implementation of change(s) for which NO 
new additional data are submitted by the MAH 
changes made to the parent product Hycamtin. 
Page 10/11 
 
 
 
 
 
 
 
 
 
IA/0002 
B.II.b.2.a - Change to batch release arrangements 
09/09/2010 
n/a 
and quality control testing of the FP - Replacement 
or addition of a site where batch control/testing 
takes place 
IA/0001 
B.II.b.1.a - Replacement or addition of a 
06/09/2010 
n/a 
manufacturing site for the FP - Secondary packaging 
site 
Page 11/11 
 
 
 
 
 
 
 
 
 
 
 
 
 
